By Kuda Pembere Zimbabwe has staged one of the region’s most remarkable immunisation recoveries, with HPV vaccine coverage soaring from just six percent in 2022 to 90 percent in 2025, making it the second-highest performer in the Southern African Development Community (SADC). The latest figures from the 2025 World Health Organization (WHO) and the United
Read More
By Michael Gwarisa Scientists have launched the world’s first clinical trial to determine whether an experimental antiviral drug can prevent people exposed to the Bundibugyo strain of Ebola virus from developing the deadly disease, offering new hope as an outbreak in the Democratic Republic of the Congo (DRC) and Uganda continues to spread. The EBO-PEP
Read More
By Michael Gwarisa WHO has officially declared the recent hantavirus outbreak over after the last person known to have been exposed to the virus completed quarantine and tested negative. Announcing the development, World Health Organization Director-General Tedros Adhanom Ghebreyesus said the final identified contact linked to the outbreak had safely completed the required monitoring period.
Read More
By Kuda Pembere Zimbabwe has received cervical cancer diagnostic equipment and cholera treatment tents worth approximately US$350,000 from the World Health Organization (WHO), a major boost to the country’s efforts to strengthen cancer care and emergency disease response. The cervical cancer equipment was secured under the Women Integrated Cancer Services (WICS) Project and will be
Read More
By Kuda Pembere Zimbabwe has become the first country in Africa and only the fourth globally to attain the World Health Organization (WHO) Global Benchmarking Tool (GBT) Maturity Level 4, the highest international standard for medicines regulation. The milestone was revealed on Wednesday by WHO Regional Director for Africa, Dr Mohamed Yakub Janabi, during a
Read More
By Michael Gwarisa African leaders, donors and international partners have pledged US$910 million towards containing the growing Ebola Bundibugyo outbreak in the Democratic Republic of Congo (DRC) and Uganda, with health officials warning that delays in releasing funds could sharply escalate both infections and costs. The commitments were announced following a High-Level Emergency Meeting convened
Read More
Michael Gwarisa The World Health Organization (WHO) and the Africa Centres for Disease Control and Prevention (Africa CDC) have launched a US$517.7 million joint continental preparedness and response plan aimed at containing the ongoing Bundibugyo Ebola outbreak and preventing its spread across Africa. The six-month plan, covering June to November 2026, seeks to strengthen surveillance,
Read More
Published First on https://www.lshtm.ac.uk/ LSHTM Vaccine Centre Co-Director Dr Muhammed Afolabi discusses the Bundibugyo Ebola outbreak, the challenges of developing a vaccine against it and how to prepare for future outbreaks. On 17 May 2026 the World Health Organization (WHO) declared the outbreak of Ebola disease in the Democratic Republic of the Congo and Uganda
Read More
Michael Gwarisa The United States has imposed emergency travel restrictions on travelers from Uganda, the Democratic Republic of Congo (DRC), and South Sudan following a growing outbreak of the rare Bundibugyo strain of Ebola, drawing concern from African health authorities who warned against punitive measures that could undermine outbreak response efforts. In an order issued
Read More
Health Correspondent A global vaccination recovery drive launched in the wake of the COVID-19 pandemic has delivered more than 100 million vaccine doses to an estimated 18.3 million children across 36 countries, helping close dangerous immunity gaps caused by years of disrupted immunisation services. The initiative, known as The Big Catch-Up (BCU), was launched during
Read More